ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an i...
FDA Device Recall #Z-1312-2018 — Class II — December 18, 2017
Recall Summary
| Recall Number | Z-1312-2018 |
| Classification | Class II — Moderate risk |
| Date Initiated | December 18, 2017 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Phadia US Inc |
| Location | Portage, MI |
| Product Type | Devices |
| Quantity | 950 total |
Product Description
ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. To be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.
Reason for Recall
The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.
Distribution Pattern
Nationwide Distribution
Lot / Code Information
Lots 990DS, Exp 2017.12.31 990DT, Exp 2018.01.31 990DW, Exp 2018.03.31 990DX, Exp, 2018.05.31 990DY
Other Recalls from Phadia US Inc
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2041-2023 | Class II | Phadia 2500EE instrument -Intended for the in v... | May 1, 2023 |
| Z-2040-2023 | Class II | EliA GliadinDP IgG Well in the Phadia 2500EE in... | May 1, 2023 |
| Z-1107-2021 | Class II | EliA dsDNA Well - Product Usage: intended for t... | Dec 14, 2020 |
| Z-1313-2018 | Class II | ImmunoCAP Allergen c6, Amoxicilloyl ( Article n... | Dec 18, 2017 |
| Z-0387-2018 | Class II | Phadia 1000 Instrument, Article Number 12-3800-01. | Jul 5, 2017 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.